Cardiovascular Disease Risk Factors in Chronic Kidney Disease: A Systematic Review and Meta-analysis

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2018 Mar 22

PMID 29561894

Citations 94

Authors

Rupert W Major

Mark R I Cheng

Robert A Grant

Saran Shantikumar

Gang Xu

Issaam Oozeerally

Nigel J Brunskill

Laura J Gray

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Chronic kidney disease (CKD) is a global health burden and is independently associated with increased cardiovascular disease risk. Assessment of cardiovascular risk in the general population using prognostic models based on routinely collected risk factors is embedded in clinical practice. In CKD, prognostic models may misrepresent risk due to the interplay of traditional atherosclerotic and non-traditional risk factors. This systematic review's aim was to identify routinely collected risk factors for inclusion in a CKD-specific cardiovascular prognostic model.

Design, Setting, Participants And Measurements: Systematic review and meta-analysis of observational cohort studies and randomized controlled trials. Studies identified from MEDLINE and Embase searches using a pre-defined and registered protocol (PROSPERO ID-2016:CRD42016036187). The main inclusion criteria were individuals ≥18 years of age with non-endstage CKD. Routinely collected risk factors where multi-variable adjustment for established cardiovascular risk factors had occurred were extracted. The primary outcome was fatal and non-fatal cardiovascular events.

Results: The review of 3,232, abstracts identified 29 routinely collected risk factors of which 20 were presented in more than 1 cohort. 21 cohorts were identified in relation to 27,465 individuals and 100,838 person-years. In addition to established traditional general population cardiovascular risk factors, left ventricular hypertrophy, serum albumin, phosphate, urate and hemoglobin were all found to be statistically significant in their association with future cardiovascular events.

Conclusions: These non-traditional risk factors should be assessed in the development of future cardiovascular prognostic models for use in individuals with CKD.

Citing Articles

Perirenal fat differs in patients with chronic kidney disease receiving different vitamin D-based treatments: a preliminary study.

Checa-Ros A, Locascio A, Okojie O, Abellan-Galiana P, DMarco L BMC Nephrol. 2025; 26(1):119.

PMID: 40045219 PMC: 11883930. DOI: 10.1186/s12882-025-04041-2.

Prevalence and associated factors of chronic kidney disease among diabetes mellitus patients in Ethiopia: A systematic review and meta-analysis.

Abuhay H, Yenit M, Melese M, Alemu G, Aragaw F PLoS One. 2025; 20(3):e0315529.

PMID: 40043039 PMC: 11882046. DOI: 10.1371/journal.pone.0315529.

Alterations in Autophagic Function and Endoplasmic Reticulum Stress Markers in the Peripheral Blood Mononuclear Cells of Patients on Hemodialysis.

Liu W, Wu M, Lim P Int J Mol Sci. 2025; 26(2.

PMID: 39859163 PMC: 11764487. DOI: 10.3390/ijms26020447.

Early Versus Late Initiation of Dialysis in CKD Stage 5: Time for a Consensus.

Abdel-Rahman E, Hasan I, Abdelrazeq A, Rawabdeh A, Liu M, Ghahramani N Kidney Int Rep. 2025; 10(1):54-74.

PMID: 39810788 PMC: 11725814. DOI: 10.1016/j.ekir.2024.10.001.

Longitudinal trend in post-discharge estimated glomerular filtration rate in intensive care survivors.

Glendell R, Puxty K, Shaw M, Sim M, Traynor J, Mark P J Intensive Care Soc. 2024; 26(1):29-37.

PMID: 39734804 PMC: 11670225. DOI: 10.1177/17511437241308673.

References

McMurray J, Uno H, Jarolim P, Desai A, de Zeeuw D, Eckardt K . Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT). Am Heart J. 2011; 162(4):748-755.e3. DOI: 10.1016/j.ahj.2011.07.016. View

Yoshitomi R, Nakayama M, Ura Y, Kuma K, Nishimoto H, Fukui A . Ankle-brachial blood pressure index predicts cardiovascular events and mortality in Japanese patients with chronic kidney disease not on dialysis. Hypertens Res. 2014; 37(12):1050-5. DOI: 10.1038/hr.2014.120. View

Kovesdy C, Trivedi B, Kalantar-Zadeh K, Anderson J . Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Nephrol Dial Transplant. 2006; 21(5):1257-62. DOI: 10.1093/ndt/gfk057. View

Shrier I, Boivin J, Steele R, Platt R, Furlan A, Kakuma R . Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. Am J Epidemiol. 2007; 166(10):1203-9. DOI: 10.1093/aje/kwm189. View

Tonelli M, Muntner P, Lloyd A, Manns B, Klarenbach S, Pannu N . Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet. 2012; 380(9844):807-14. DOI: 10.1016/S0140-6736(12)60572-8. View

Bowling C, Pitt B, Ahmed M, Aban I, Sanders P, Mujib M . Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies. Circ Heart Fail. 2010; 3(2):253-60. PMC: 2909749. DOI: 10.1161/CIRCHEARTFAILURE.109.899526. View

Gorriz J, Molina P, Cerveron M, Vila R, Bover J, Nieto J . Vascular calcification in patients with nondialysis CKD over 3 years. Clin J Am Soc Nephrol. 2015; 10(4):654-66. PMC: 4386255. DOI: 10.2215/CJN.07450714. View

Alderson H, Ritchie J, Middleton R, Larsson A, Larsson T, Kalra P . FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5. Nephrology (Carlton). 2016; 21(7):566-73. DOI: 10.1111/nep.12664. View

Meijers B, Poesen R, Claes K, Dietrich R, Bammens B, Sprangers B . Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease. Kidney Int. 2014; 87(1):210-6. DOI: 10.1038/ki.2014.197. View

10.

Spoto B, Mattace-Raso F, Sijbrands E, Leonardis D, Testa A, Pisano A . Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD. Clin J Am Soc Nephrol. 2014; 10(2):232-40. PMC: 4317745. DOI: 10.2215/CJN.07000714. View

11.

Kim R, Morse B, Djurdjev O, Tang M, Muirhead N, Barrett B . Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events. Kidney Int. 2016; 89(5):1144-1152. DOI: 10.1016/j.kint.2016.01.014. View

12.

Riley R, Abrams K, Sutton A, Lambert P, Jones D, Heney D . Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future. Br J Cancer. 2003; 88(8):1191-8. PMC: 2747576. DOI: 10.1038/sj.bjc.6600886. View

13.

Hasegawa M, Ishii J, Kitagawa F, Takahashi K, Hayashi H, Koide S . Urinary neutrophil gelatinase-associated lipocalin as a predictor of cardiovascular events in patients with chronic kidney disease. Heart Vessels. 2014; 30(1):81-8. DOI: 10.1007/s00380-013-0454-7. View

14.

Turner E, Dobson J, Pocock S . Categorisation of continuous risk factors in epidemiological publications: a survey of current practice. Epidemiol Perspect Innov. 2010; 7:9. PMC: 2972292. DOI: 10.1186/1742-5573-7-9. View

15.

Chandra P, Sands R, Gillespie B, Levin N, Kotanko P, Kiser M . Predictors of heart rate variability and its prognostic significance in chronic kidney disease. Nephrol Dial Transplant. 2011; 27(2):700-9. PMC: 3616757. DOI: 10.1093/ndt/gfr340. View

16.

Altman D, Royston P . The cost of dichotomising continuous variables. BMJ. 2006; 332(7549):1080. PMC: 1458573. DOI: 10.1136/bmj.332.7549.1080. View

17.

Kerr M, Bray B, Medcalf J, ODonoghue D, Matthews B . Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant. 2012; 27 Suppl 3:iii73-80. PMC: 3484716. DOI: 10.1093/ndt/gfs269. View

18.

Ninomiya T, Perkovic V, Turnbull F, Neal B, Barzi F, Cass A . Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. BMJ. 2013; 347:f5680. PMC: 3789583. DOI: 10.1136/bmj.f5680. View

19.

Paoletti E, De Nicola L, Gabbai F, Chiodini P, Ravera M, Pieracci L . Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension. Clin J Am Soc Nephrol. 2015; 11(2):271-9. PMC: 4741044. DOI: 10.2215/CJN.06980615. View

20.

Matsushita K, van der Velde M, Astor B, Woodward M, Levey A, de Jong P . Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010; 375(9731):2073-81. PMC: 3993088. DOI: 10.1016/S0140-6736(10)60674-5. View